4//SEC Filing
Sigal Charles Elliott 4
Accession 0001209191-23-014673
CIK 0001706431other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:27 PM ET
Size
6.2 KB
Accession
0001209191-23-014673
Insider Transaction Report
Form 4
Sigal Charles Elliott
Director
Transactions
- Purchase
Common Stock
2023-03-01$22.73/sh+2,500$56,816→ 10,000 total(indirect: By LLC)
Holdings
- 9,779
Common Stock
Footnotes (3)
- [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sigal Family Investments, LLC on October 21, 2022, of which the reporting person is the manager.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.595 to $22.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F3]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001661908
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:27 PM ET
- Size
- 6.2 KB